The co-founders of Fred Hutch's oncology therapeutics developer include Philip Greenberg who previously helped launch Juno Therapeutics.

Affini-T Therapeutics, a US-based cancer therapy spinout of Fred Hutchinson Cancer Research Center, has closed an oversubscribed $175m round featuring the centre itself and The Parker Institute for Cancer Immunotherapy.

Leaps by Bayer, a subsidiary of pharmaceutical and chemicals group Bayer, and life sciences-focused investment firm Vida Ventures, which co-founded Affini-T, co-led the round, which included Alexandria Venture Investments, a vehicle for life sciences and property investment trust Alexandria Real…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.
Email LinkedIn